Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Hemodynamic Monitoring-Guided Goal-Directed Fluid Therapy in Robotic Radical Prostatectomy

NCT07806539 · Antalya Training and Research Hospital · Updated 8 Sept 2026

What is being tested
LiDCO-guided goal-directed fluid therapy; Conventional fluid therapy
For
Prostate Cancer; Robotic Radical Prostatectomy
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 48 people. The full rules are on the registry page.
Where
Turkey (Türkiye)
When
Starts or started 23 Feb 2026, ends 15 Aug 2026. Registered 8 Sept 2026.
Results
None posted yet.

In the researchers' words

This prospective observational cohort study evaluated goal-directed fluid therapy guided by minimally invasive hemodynamic monitoring in adult male patients undergoing elective robotic radical prostatectomy. Patients were prospectively enrolled and followed according to the intraoperative fluid management strategy used in routine clinical practice. Patients managed with LiDCO®Rapid-guided goal-directed fluid therapy constituted the hemodynamic monitoring-guided group, while patients managed with conventional intraoperative fluid therapy constituted the control group. No randomization or additional research-related intervention was performed. The study compared the two fluid management strategies with respect to intraoperative crystalloid fluid administration and selected perioperative clinical and laboratory parameters.
ClinicalTrials.gov, NCT07806539

Sites

  • Antalya Training and Research HospitalAntalya, Turkey (Türkiye)